Provided by Tiger Fintech (Singapore) Pte. Ltd.

Disc Medicine

52.24
-0.9900-1.86%
Post-market: 52.240.00000.00%18:30 EDT
Volume:1.08M
Turnover:56.92M
Market Cap:1.81B
PE:-13.19
High:54.01
Open:52.87
Low:52.06
Close:53.23
Loading ...

Company Profile

Company Name:
Disc Medicine
Exchange:
NASDAQ
Establishment Date:
2017
Employees:
84
Office Location:
321 Arsenal Street,Suite 101,Watertown,Massachusetts,United States
Zip Code:
02472
Fax:
- -
Introduction:
Disc Medicine Opco Inc, together with its subsidiaries, operates as a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. The company builds a portfolio of fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. It also develops bitopertin for the treatment of erythropoietic porphyrias, erythropoietic protoporphyria, and X-linked protoporphyria. In addition, the company develops DISC-0974 for the treatment of chronic kidney disease; MWTX-003 for the treatment of polycythemia vera, and other hematologic disorders; and DISC-0998 for the treatment of anemia associated with inflammatory. The company is based in Watertown, Massachusetts.

Directors

Name
Position
Jason Meyenburg
President,Chief Executive Officer,Director
Georges Gemayel
Chair of the board
David Lubner
Director
Jason Rhodes
Director
Jim Tananbaum
Director
Tuyen Ong
Director

Shareholders

Name
Position
Jason Meyenburg
President,Chief Executive Officer,Director
Brian Piekos
Chief Financial Officer
Marc Uknis
Chief Medical Officer
Scott Lauder
Chief Technology Officer